BARCLAYS PLC - COMPASS THERAPEUTICS INC ownership

COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 1 filers reported holding COMPASS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of COMPASS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$59
-41.6%
30,303
-5.1%
0.00%
Q2 2023$101
-24.6%
31,921
-22.1%
0.00%
Q1 2023$134
+47.3%
40,986
+124.9%
0.00%
Q4 2022$91
-90.9%
18,225
+4773.0%
0.00%
Q3 2022$1,0003740.00%
Other shareholders
COMPASS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 1,246,977$2,456,5453.92%
CHI Advisors LLC 2,829,712$5,574,5322.21%
Ally Bridge Group (NY) LLC 914,630$1,801,8212.12%
Monashee Investment Management LLC 1,226,142$2,415,5001.01%
Orbimed Advisors 22,362,850$44,054,8150.94%
Vivo Capital, LLC 3,556,023$7,005,3650.77%
CAXTON CORP 86,773$170,9420.65%
Prosight Management, LP 935,157$1,842,2590.58%
BRAIDWELL LP 5,954,273$11,729,9180.37%
Rock Springs Capital Management LP 5,513,788$10,862,1620.29%
View complete list of COMPASS THERAPEUTICS INC shareholders